NCT01078753 - Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Nocturnal Enuresis

Interventions

DRUG

Desmopressin

Desmopressin oral lyophilisate tablet, 120 μg or 240 μg, administered sublingually once a day 1½ hours before bedtime.

DRUG

Placebo

Placebo oral lyophilisate tablet was administered sublingually once a day 1½ hours before bedtime.

Trial Locations (15)

Akita University Hospital, Akita

Hiroshima Red Cross Hospital and Atomic Bomb Survivors Hospital, Hiroshima

Showa Hospital, Amagasaki

Shinko-Kakogawa Hospital, Kakogawa

Tamura Children's Clinic, Mito

Shinbo Child Clinic, Yokohama

Aikawa Station Clinic, Niigata

Kansai Medical University Hirakata Hospital, Hirakata

Kitano Hospital, Osaka

Saitama Childrens Medical Centre, Saitama

Shintoshin Child Clinic, Saitama

Takesue Children's Clinic, Musashino

Juntendo University Nerima Hospital, Nerima City

Saitoh Pediatric Medical Clinic, Nishitōkyō

Hoashi Children's Psychological Clinic, Setagaya City